Clinical Trials · NCT00124514

Triptorelin for Ovary Protection in Childhood Onset Lupus

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
31
Start date
Jun 2003
Locations
10 sites, United States, Brazil
Primary endpoint
Dose of Triptorelin for Ovarian Suppression
View Gonadorelin compound reference